showed that hypernickelemia is not specific for myocardial infarction, because nickel concentrations in serum are also increased in patients with cerebral stroke and thermal burns, as well as in some patients with myocardial ischemia without infarction.
concentrations in serum of 25 of 35 patients with acute myocardial infarction, sampled 12 to 36 h after onset of symptoms. Such frequent occurrence of hypernickelemia after acute myocardial infarction has been confirmed by investigators in England (4), Germany (5) , the USSR (6), and Pakistan (7) . McNeely et al. (8) showed that hypernickelemia is not specific for myocardial infarction, because nickel concentrations in serum are also increased in patients with cerebral stroke and thermal burns, as well as in some patients with myocardial ischemia without infarction.
During the decades since the initial studies of serum nickel concentrations in patients with myocardial infarction, the accuracy and precision of analyses for nickel in body fluids have gradually been improved and the detection limits for nickel have steadily declined (9-11). It is now feasible to measure serum nickel concentrations in 1-mL 'Department of Medicine, New Britain General Hospital, New Britain, CT 06050. 2Department of Laboratory Medicine, University of Connecticut Medical School, Farmington, CT 06032.
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Received January 24, 1985 ; accepted January 29, 1985. samples (12) , as compared with 10-mL samples in 1970 (2). The techniques for collecting specimens and avoiding nickel contamination during sample processing have also been substantially refined (9) (10) (11) (12) . As a consequence, reference values for nickel concentrations in sera of healthy persons have diminished from 2.6 (SD 0.8) .tg/L in 1970 (2) to 0.46 (SD 0.26) ig/L in 1984 (12) .
The principal goal of the present study was to reinvestigate the incidence, magnitude, and time-course of hypernickelemia in patients with acute myocardial infarction, with application of stringent clinical criteria, up-to-date analytical instrumentation, and utmost precautions to minimize contamination of samples with nickel. Additional populations for this study included (a) healthy adult residents of central Connecticut, (b) patients with unstable angina pectoris who were admitted to the cardiovascular intensive care unit, but who did not subsequently develop electrocardiographic or biochemical signs of acute myocardial infarction, and (c) patients with coronary atherosclerosis, who were tested before and after strenuous exercise on a treadmill.
Protocol and Methods
The protocol for this study was approved by the Human Experimentation
Committees of the New Britain General Hospital and the University of Connecticut Health Center; each participant gave infonned consent in writing.
Blood specimens were collected with polyethylene intravascular cannulae, polypropylene syringes, and polyethylene test tubes, with precautions to avoid contamination with nickel (10,12). Nickel-free heparin from bovine lung (Sigma Chemical Co., St. Louis, MO 63178) was used as the anticoagulant for whole-blood specimens. Nickel concentrations in serum and whole blood were analyzed in duplicate by electrothermal atomic absorption spectrophotometry, as described by Sunderman et al. (12) , in a Model 5000 spectrometer with automatic sampler, pyrolytic graphite tubes, and Zeeman background correction system (PerkinElmer Corp., Norwalk, CT 06856). The detection limit for nickel was 0.05 g/L; coefficients of variation for replicate nickel analyses averaged 3.8% (within-run) and 8.1% (dayto-day); analytical recovery of nickel, added to 16 sera to give a concentration of 8 pg/L, averaged 97% (SD ± 3%); analytical recovery of nickel similarly added to 13 samples of whole blood averaged 103% (SD ±6%). Nickel concentrations in 30 sera, measured by the method of Sunderman et al. (12), did not differ significantly (r = 0.980) from results obtained by the IUPAC Reference Method (10). Nickel was measured in urine specimens by electrothermal atomic absorption spectrophotometry, after acid digestion, chelation, and solvent extraction, all according to the IUPAC Reference Method (10).
The healthy control subjects were 30 asymptomatic adult residents of central Connecticut (15 men, 15 women, ages 23 to 84 years), who were not receiving medications, including oral contraceptives, and who gave no history of heart disease To determine whether delay in serum separation from the blood might affect nickel concentrations in serum specimens, we collected four tubes of blood from each of five healthy subjects. The tubes were placed in a refrigerator (10 #{176}C), and one tube from each subject was centrifuged for serum separation at 1, 4, 8, and 20 h, respectively, after venepuncture.
As indicated in Table 1 , there were no significant changes from the initial values for serum nickel concentrations by paired-sample t-test, indicating that blood specimens could be stored at 10 #{176}C for as long#{225}a 20h before removal of serum. This finding made it feasible to collect blood specimens for serum nickel analysis from patients in the cardiovascular intensive-care unit during the night work-shifts.
To determine whether diurnal or post-prandial fluctuations of nickel metabolism might be confounding factors in this study, we obtained nine specimens of serum and timed collections of urine from two healthy subjects during a 36-h period. As shown in Table 2 , there were no significant diurnal or post-prandial variations of serum nickel concentrations. We noted considerable fluctuation in the urinary excretion of nickel, but saw no clear-cut circadian pattern. or occupational exposure to nickel. Specimens of serum and heparinized whole blood were obtained from these (nonfasting) subjects at various times during the working hours. To test for circadian variations of nickel concentrations, specimens of serum and urine were collected from two healthy controls on nine occasions during a 36-h period. To test for exercise-induced fluctuations of nickel concentrations, sera were obtained from seven healthy controls (four men, three women) before, immediately after, and 3 h after an 8-km cross-country run, and from two healthy controls before and immediately after maximal exertion for 15 mm on a treadmill.
The patients included 87 adult residents of central Connecticut (58 men, 29 women, ages 30 to 89 years), who were admitted to the cardiovascular intensive-care unit at New Britain General Hospital with the provisional diagnosis of suspected myocardial infarction. Three to six blood specimens were collected for nickel analysis within 72 h of admission, including two or three specimens during the first hospital day. In selected cases, blood sampling was continued for five to seven days.
The first tube of blood, which was collected through the polyethylene intravenous cannula, was used for routine diagnostic tests, including analyses for serum creatine kinase (CK; EC 2.7.3.2) activity and fractionations of CK isoenzymes (13, 14). The second tube of blood was used for analysis for serum nickel; when feasible, a third tube was collected for analysis for nickel in heparinized whole blood. patients with new Q waves or their equivalent were not included in this group. The patients who were diagnosed as having unstable angina pectoris did not develop increased serum CK activity or increased proportion of the CK-MB isoenzyme.
Five additional patients (men, ages 42 to 73 years) who had unequivocal angiographic evidence of coronary atherosclerosis were studied to determine the effects of exerciseinduced cardiac ischemia on serum nickel concentrations. Sera for nickel analysis were obtained before and immediately after an exercise tolerance test. These patients all developed cardiac ischemia during maximal exertion on the treadmill, as manifested by angina pectoria or electrocardiographic abnormalities, or both.
Statistical computations, including
standard deviation, Student's paired and non-paired t-test, the chi-square test, sign test, Mann-Whitney U test, linear regression, and correlation coefficient were performed as described by Goldstein (15). 'Four blood specimensfromeach subject were storedat 10#{176}C. The tubes were centrifuged and sera were separated at the specified intervals after venepuncture.No significantchanges from the Initialvalues were found by the paired-samplet-testorthe sign test. Table 3) . The concentrations of nickel in whole-blood specimens were slightly lower than previously reported (12), owing to the availability of heparin that contained no detectable nickel. Nickel concentrations in sera collected from seven healthy subjects after an 8-km cross-country run, and in sera from two healthy subjects after maximal exertion for 15 miii on a treadmill, did not reveal any significant differences from the corresponding nickel concentrations in pre-exercise sera, based upon the paired-sample t-test (data not shown). The serum nickel concentrations in the post-exertion specimens were within the reference range (<0.05-1.1 zg/L) .
In Table 4 we compare serum nickel concentrations in patients with acute.myocardial infarction with the results for patients with unstable angina pectoris. There were clear-cut peaks of serum CK activity, which generally occurred within 6 to 18 h after admission, and of serum nickel concentration, which generally occurred within 12 to 48 hours after admission, in 41 of the patients with acute myocardial infarction. The mean interval between the peak value for serum CK activity and the peak value for serum nickel concentration was 18 h. The nickel concentration in serum was greatest 8 to 48 h after the value for serum CK activity reached its maximum in 30 of the 41 patients (73%); the two peak values occurred simultaneously in eight patients (20%); the peak value for serum nickel concentration occurred 8 to 24 h before the peak value for serum CK activity in three patients (7%). In two patients, biphasic increases of serum nickel concentration were observed, although there were only single peaks of serum CK activity (Figure 1 ). Both patients experienced recurrent chest pain at rest after the second peak in serum nickel, although their electrocardiograms and serum CK activities did not indicate extensions of the myocardial infarcta. The bouts of recurrent chest pain were consistent with coronary vasopasm.
Whole-bloodspecimens were obtained for nickel analysis from 16 patients with acute myocardial infarction. Figure 2 shows comparisons of nickel concentrations in 50 paired specimens of whole blood and serum from these patients, collected during 72 h after admission. Blood hematocrit values in these patients ranged from 45 to 50%, so the increased concentrations of nickel in serum were associated with little, if any, increases of nickel concentrations in erythrocytes.
Hypernickelemia ( Infarction during 72 h afteradmission to thecardiovascular intensivecareunit.
(77%) with acute myocardial infarction who were treated with calcium-blocking drugs (nifedipine, diltiazem, or verapamil). This incidence did not differ significantly from the occurrence of hypernickelemia in 21 of 28 patients (75%) with acute myocardial infarction who did not receive calcium-blocking drugs. Hypernickelemia was observed in two of three patients with acute myocardial infarction who were being treated with streptokinase.
There was no evidence that hypernickelemia in patients with acute myocardial infarction or unstable angina pectoris is associated with administration of any other drug. Serum nickel concentrations were unrelated to age, sex, race, occupation, time of day, cigarette smoking, hypotension, arrhythmias, congestive heart failure, pulmonary edema, or clinical complications. Hypernickelemia was found in two of three patients who died within three weeks after an acute myocardial infarction.
Sera from seven patients, collected after their complete recovery from acute myocardial infarction and discharge from the hospital, showed normal nickel concentrations one to six months post-infarction (Table 5) . We analyzed serum sampled from five men with angiographic evidence of advanced coronary atherosclerosis, before and immediately after maximal exercise testing on a treadmill. These patients all developed angina pectoris or diagnostic electrocardiographic abnormalities, or both, during the exercise tolerance test. One of the patients had hyperrnckelemia (3.8 ig/L) before exercise; his serum nickel concentration after exercise was lower, but still above normal (1.4 zg/L). In the other four subjects, serum nickel concentrations were not significantly altered after exerciseinduced cardiac ischemia (Table 6) .
Discussion
This study demonstrates that hypernickelemia develops in three-fourths of patients with acute myocardial infarction and in approximately half of patients with unstable angina pectoris, based upon analyses by a sensitive, precise, and specific technique, with precautions to minimize nickel contamination.
Although nickel concentrations
in sera from healthy control subjects are lower by the present technique than were obtained by earlier methods, the post-infarction increments in serum nickel concentrations that were observed in this study are similar to those reported by Sunder- sistent with the reports of previous workers (2,4, 5, 7, 8) . The present study indicates that therapy with calciumblocking drugs does not affect the incidence of hypernickelemia in patients with acute myocardial infarction.
On the basis of measurements of nickel concentrations in hearts from previously healthy subjects who died suddenly from murder or suicide, Sunderman et al. estimated that the normal human heart contains approximately 1.8 zg of nickel. Even if nickel were to be completely released from cardiac tissue after myocardial infarction and if the released nickel were distributed solely within a serum volume of 2.5 L, the resulting increase in serum nickel concentration would be only 0.7 .tg/L. Therefore, Sunderman et al. (3) suggested that hypernickelemia in patients with acute myocardial infarction is unlikely to be caused by postnecrotic release of the nickel that normally is present in the heart. This deduction is strengthened by the present study, because we often observed hypernickelemia in patients with unstable angina pectoris, without electrocardiographic or biochemical evidence of myocardial injury or necrosis.
We consider three hypotheses to explain the source and mechanism of hypernickelemia in patients with acute myocardial infarction or unstable angina pectoris: First, the myocardiuni or coronary arteries of patients with atherosclerotic heart disease (a) may contain abnormally increased concentrations of nickel and (b) when stunned by ischemia, may release nickel into the circulation. Part a of this hypothesis is being tested by analyses for nickel in cardiac tissue samples obtained post-mortem from patients with coronary atherosclerosis.
Contrary to part b of this hypothesis, patients with coronary atherosclerosis failed to develop hypernickelemia following exercise-induced myocardial ischemia.
Second, hypernickelemia may be a secondary phenomenon, mediated by release of nickel from another organ, in response to stress, hypotension, congestive heart failure, or pulmonary edema. The lung would be a likely source of nickel, because human lung tissue accumulates nickel with advancing age (11). However, correlation between occurrence of hypernickelemia and presence of hypotension, congestive heart failure, or pulmonary edema was not evident in this study. Third, nickel may be bound to clotting factors or complement components, and released into serum during the coagulation cascade that occurs during coronary thrombosis or during the activation of the alternative complement pathway that follows myocardial inflammation. These speculations are prompted by recent findings that human factor Vifi and C-3 convertase contain metal-binding sites that may form complexes with Ni2 (16, 17) . in rats after acute burns or hemorrhagic shock, suggesting a role of nickel in the coronary spasm that occurs in these disorders. This speculation is consistent with the possible occurrence of coronary spasm following hypernickelemia in two of our patients (Figure 1) . Recent studies by other workers (23-25) demonstrate that Ni2 can act directly upon the myocardium to induce electrophysiological disturbances, possibly mediated by inhibition of the slow inward Ca2 current.
We conclude that the mechanisms and sources of nickel release into sera of patients with acute myocardial infarction or unstable angina pectoris are conjectural, but it appears that hyperrnckelemia may somehow be related to the pathogenesis of ischemia myocardial injury.
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